TrialBMC cancer2022

Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study.

Luigi Celio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.